COMPASS Pathways PLC ADR (CMPS): Price and Financial Metrics
CMPS Price/Volume Stats
| Current price | $4.66 | 52-week high | $12.75 |
| Prev. close | $4.76 | 52-week low | $4.05 |
| Day low | $4.59 | Volume | 504,000 |
| Day high | $4.88 | Avg. volume | 632,724 |
| 50-day MA | $6.01 | Dividend yield | N/A |
| 200-day MA | $7.65 | Market Cap | 318.84M |
CMPS Stock Price Chart Interactive Chart >
COMPASS Pathways PLC ADR (CMPS) Company Bio
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation that is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom.
CMPS Price Returns
| 1-mo | -26.84% |
| 3-mo | -35.19% |
| 6-mo | -37.70% |
| 1-year | -22.98% |
| 3-year | -84.58% |
| 5-year | N/A |
| YTD | -46.74% |
| 2023 | 8.97% |
| 2022 | -63.67% |
| 2021 | -53.61% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...